G1 Therapeutics Inc (STU:G1H)
€ 6.39 0 (0%) Market Cap: 339.15 Mil Enterprise Value: 327.68 Mil PE Ratio: 0 PB Ratio: 15.31 GF Score: 32/100

Q1 2021 G1 Therapeutics Inc Earnings Call Transcript

May 05, 2021 / 08:30PM GMT
Release Date Price: €16.52 (-0.84%)
Operator

Ladies and gentlemen, thank you for standing by and welcome to the G1 Therapeutics 2021 first quarter financial results conference call. At this time all participants are in a listen-only mode. After the speaker's presentation, there will be a question and answer session. (Operator Instructions). I would now like to hand the conference over to our speaker today, Mr. Will Roberts, please go ahead.

William C. Roberts
G1 Therapeutics, Inc. - VP of IR & Corporate Communications

Thank you Julian. Good afternoon everyone and welcome to the G1 conference call to discuss our first quarter 2021 financial results and business update. The press release on these financial results was issued after market close this afternoon and can be found in the news section of our corporate website, g1therapeutics.com. On this afternoon's call, the team will provide a business overview of the first quarter, including an update on our launch progress with COSELA, which was approved by the US Food and Drug Administration on February 12th, 2021 to decrease the incidence of chemotherapy

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot